Gene therapy treatment for hereditary eye disease will cost $850,000
The treatment’s developer is exploring a payment plan option.
Novartis
First FDA-approved genetic therapy fights leukemia
The procedure modifies a patient's autologous cells to target the cancer.
Alphabet's autofocusing contact lens won't be tested in 2016
Novartis doesn't know when the partnership will be ready to start human tests.
